The goal of this project was to develop a vaccination strategy that would enhance the
protective humoral immune response against the flagellin protein of Pseudomonas …

The focus of this research is the development of a vaccine for the prevention of acute
infection by Pseudomonas aeruginosa. A DNA vaccine was developed using the flagellin …

Purpose: P. aeruginosa is the epitome of an opportunistic pathogen of humans. It causes a
variety of serious illness and represents a major risk among patients with cystic fibrosis …

Pseudomonas aeruginosa is a serious pathogen in hospitalized, immunocompromised, and
cystic fibrosis (CF) patients. P. aeruginosa is motile via a single polar flagellum made of …

Pseudomonas aeruginosa is an opportunistic pathogen that causes severe and lethal
infections in immunocompromised individuals. This bacterium possesses a single polar …

The goal of this study was to investigate if antibodies raised against N'-terminal
Pseudomonas aeruginosa (Pa) flagellin could afford protection in two lethal mouse models …

Immunogenicity and efficacy of Pseudomonas aeruginosa type a and b flagellins (hereafter,
flagellins) as candidate vaccines were evaluated using an experimental burned mouse …

Recent reports have suggested that motility is associated with virulence in Pseudomonas
aeruginosa. We have confirmed this observation by showing that groups of mice immunized …

To address the problem of increased antimicrobial resistance, we developed a
glycoconjugate vaccine comprised of O-polysaccharides (OPS) of the four most prevalent …

Pseudomonas aeruginosa is the leader among gram-negative bacteria in causing burn
wound infections. Exotoxin A (ETA) is a major virulence factor that produced by this …